232 related articles for article (PubMed ID: 18695131)
1. SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care.
Wilt TJ
J Natl Cancer Inst; 2008 Aug; 100(16):1123-5. PubMed ID: 18695131
[No Abstract] [Full Text] [Related]
2. A plea to young surgeons dealing with radical prostatectomy patients: invest your time and intellectual energy in optimizing your research methodology and keep your feet on the ground.
Montorsi F
Eur Urol; 2010 Dec; 58(6):847-8. PubMed ID: 20926178
[No Abstract] [Full Text] [Related]
3. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Korfage IJ
Eur Urol; 2009 Feb; 55(2):432. PubMed ID: 18783875
[No Abstract] [Full Text] [Related]
4. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer.
D'Amico AV; Chen MH
J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151
[No Abstract] [Full Text] [Related]
6. Early versus delayed intervention for prostate cancer: the case for early intervention.
Loeb S; Catalona WJ
Nat Clin Pract Urol; 2007 Jul; 4(7):348-9. PubMed ID: 17563779
[No Abstract] [Full Text] [Related]
7. On call. September 11 was an emotional day for all of us, but September 12 was a confusing day for me. I read two newspapers that reported on research in the New England Journal of Medicine. The New York Times headline said: "Prostate cancer surgery found to cut death risk," but the Washington Post announced: "Studies find no advantage to prostate cancer surgery." Which was right?
Simon HB
Harv Mens Health Watch; 2002 Dec; 7(5):8. PubMed ID: 12499134
[No Abstract] [Full Text] [Related]
8. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care for radical prostatectomy in the United States from 2003 to 2005.
Hu JC; Hevelone ND; Ferreira MD; Lipsitz SR; Choueiri TK; Sanda MG; Earle CC
J Urol; 2008 Nov; 180(5):1969-74. PubMed ID: 18801512
[TBL] [Abstract][Full Text] [Related]
10. Clinical research done by the Scandinavian Prostate Cancer Group during the first 20 years.
Høisaeter PA; Vaage S; Hedlund PO
Scand J Urol Nephrol Suppl; 2003; (212):7-10. PubMed ID: 12841320
[TBL] [Abstract][Full Text] [Related]
11. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Johansson E; Bill-Axelson A; Holmberg L; Onelöv E; Johansson JE; Steineck G;
Eur Urol; 2009 Feb; 55(2):422-30. PubMed ID: 18783877
[TBL] [Abstract][Full Text] [Related]
12. Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial.
Schulz RJ; Kagan AR
J Natl Cancer Inst; 2009 Jan; 101(2):124. PubMed ID: 19141784
[No Abstract] [Full Text] [Related]
13. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
14. Radical prostatectomy as treatment for prostate cancer.
Jewett MA; Fleshner N; Klotz LH; Nam RK; Trachtenberg J
CMAJ; 2003 Jan; 168(1):44-5. PubMed ID: 12515785
[No Abstract] [Full Text] [Related]
15. Predicting cancer outcome after prostate removal.
Mayo Clin Health Lett; 2006 Jul; 24(7):4. PubMed ID: 16869041
[No Abstract] [Full Text] [Related]
16. Surgery no better than observation for localized prostate cancer.
Printz C
Cancer; 2012 Nov; 118(22):5452-3. PubMed ID: 23129387
[No Abstract] [Full Text] [Related]
17. [Screening for prostate cancer: results from the first screening round in the French population of the ERSPC trial].
Richard F
Prog Urol; 2009 Jul; 19(7):499-500. PubMed ID: 19559381
[No Abstract] [Full Text] [Related]
18. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI
Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223
[TBL] [Abstract][Full Text] [Related]
19. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Gattellari M; Ward JE
Eur Urol; 2009 Feb; 55(2):431. PubMed ID: 18783873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
